New Zealand’s health regulator Medsafe has approved the paediatric Pfizer vaccine against Covid-19 for children of age 5 to 12 years, the health ministry said in a statement.

• PM Modi to Inaugurate Noida Airport on 28th March
• Fullife Raises Rs 300 Cr, IPO Plans a Few Years Away
• NBD Bank Gets Nod from Central Bank to Acquire Stake in RBL Bank
• LIC Gets Slammed with Rs 6,146 Crore Tax Demand
• L&T Tech Planning to Sell its Unit to AMI Paradigm Solutions

The temporary approval is for two doses of the paediatric Pfizer Covid-19 vaccine, which can be given in at least 21 days break, the statement said. If the cabinet approves the vaccine, the paediatric Pfizer vaccine will be started in New Zealand by the end of January 2022, the health ministry added.